NOVOZYMES A/S SPONS.ADR 1 (NZM) — Cash Flow Reinvestment Rate
NOVOZYMES A/S SPONS.ADR 1 (NZM) has a Cash Flow Reinvestment Rate of 0.56x as of March 2026, reinvesting €93.10 Million (capex €93.10 Million ) from operating cash flow of €167.10 Million. Explore NOVOZYMES A/S SPONS.ADR 1 capital spending ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NOVOZYMES A/S SPONS.ADR 1 Cash Flow Reinvestment Rate (2021–2025)
Historical reinvestment intensity for NOVOZYMES A/S SPONS.ADR 1 across 5 annual periods. Also explore NOVOZYMES A/S SPONS.ADR 1 assets under control for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for NOVOZYMES A/S SPONS.ADR 1 (2021–2025)
Year-by-year capital reinvestment analysis for NOVOZYMES A/S SPONS.ADR 1. For live market cap and broader valuation context, see NZM market cap overview.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.39x | €470.80 Million | €1.22 Billion | €470.80 Million | ▲ +9.3% |
| 2024 | 0.35x | €359.80 Million | €1.02 Billion | €359.80 Million | ▼ -28.7% |
| 2023 | 0.50x | €275.80 Million | €557.10 Million | €275.80 Million | ▼ -31.4% |
| 2022 | 0.72x | €387.87 Million | €537.65 Million | €387.87 Million | ▲ +136.3% |
| 2021 | 0.31x | €166.73 Million | €546.17 Million | €166.73 Million | — |